or
Bookmark and Share
Drug combinations comprising (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[meth- ylsulfonyl)amino] pyrimidin-5-yl] (3r,5s) -3,5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of p450 isoenzyme 3A4
   
Document Number
US Patent 6982157
Issued Date
January 3, 2006
Link
Inventors
Pears; John S (Macclesfield,GB)
Raza; Ali (Wilmington, DE)
Map
Abstract
The invention concerns safe non-interacting drug combinations of a 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, which is (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)a- mino]pyrimidin-5-yl](3R,5S)-3,5 -dihydroxyhept-6-enoic acid or a pharmaceutically acceptable salt thereof (the Agent) and a drug which is either an inducer, inhibitor or a substrate of cytochrome P450, in particular cytochrome P450 isoenzyme 3A4. Particular combinations are useful in treating hyperlipidaemia in humans who are receiving immunosuppressive chemotherapy. A preferred combination is the Agent and a fibrate drug, the use of such a combination in treating hyperlipidaemia in mammals, and medicaments containing such a combination for use in such treatments.
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
4
Comments:
no comments yet
Owner
AstraZeneca AB (London,GB)
Published
January 3, 2006
Application Number
09/889,414
Filed
February 1, 2000
US Classification
435/184  
Int'l Classification
C12N   9/99   (20060101)  
Examiner
Attorney/Law Firm
Priority Data
Feb 06, 1999 [GB] 9902593 Sep 08, 1999 [GB] 9921063 Sep 08, 1999 [GB] 9921064
USPTO Field of Search
519/9  
Related Patents
7129352 - Crystalline salts of 7-'4-(4-fluorophenyl) -6-isopropyl-2-'methyl (methylsulfonyl) amino!pyrimidin-5-yl!- (3R, 5S) -3, 5-dihydroxyhept-6-enoic acid - Owned by AstraZeneca AB (Sodertalje,SE) Shionogi & Co., Ltd. (Osaka,JP)

The invention relates to crystalline salts of the compound (E)-7-[4-(4-fluorophenyl)isopropyl-2-[methyl(methylsulfonyl)amino]pyrimid- in-5-yl]-(3R,5S)-3,5-dihydroxyhept-6-enoic acid of formula (I), as well as processes for their manufacture, pharmaceutical compositions containing them, and their uses ##STR00001##

Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us